Key medicines likely to get costlier soon

Invoking for the first time a provision “in public interest’’, the drug prices regulator NPPA on Friday revised prices of 21 formulations, allowing a one-time increase of 50% from the existing ceiling price. The NPPA’s move is in response to the pharma industry’s requests over the last two years to allow upward revision in prices.

from Times of India https://ift.tt/2RTQaCn